SIGN IN
Study Operations Lead jobs in United States
cer-icon
Apply on Employer Site
company-logo

TG Therapeutics, Inc. · 2 days ago

Study Operations Lead

TG Therapeutics is a fully-integrated, commercial-stage, biopharmaceutical company focused on novel treatments for B-cell diseases. The Study Operations Lead is responsible for the end-to-end execution of clinical studies, facilitating collaboration among study teams, ensuring trial oversight, and managing risks while communicating updates.
BiotechnologyHealth CareTherapeutics
check
H1B Sponsor Likelynote
Hiring Manager
Rachel Berger-Rosas, MBA
linkedin

Responsibilities

Primary Clinical Operations point of contact for a specific study or set of studies
Provides oversight and project management activities throughout the project lifecycle of the trial, including timelines and deliverables from all functional areas and vendors
Develops and maintains study documents, trackers, and key study information
Works with the cross-functional project team to identify and evaluate issues and risks in the program and suggests and implements solutions
Communicates study information to team members and TG leadership
Leads or contributes to process improvement initiatives, audits and inspections

Qualification

Clinical TrialsClinical Research ProcessFDA RegulationsProject ManagementComputer SkillsVerbal CommunicationWritten CommunicationTime ManagementOrganizational Skills

Required

Experience in Clinical Trials
Experience and ability to provide the organization with the skills required to lead a clinical trial team
Thorough knowledge of clinical research process
Knowledge of FDA and global regulations and their practical implementation
Strong verbal and written communication skills
Proficient computer skills
Ability to manage and prioritize workload effectively. Excellent time management, project coordination, and organizational skills
University degree in life sciences or related fields

Company

TG Therapeutics, Inc.

twittertwittertwitter
company-logo
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

H1B Sponsorship

TG Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)

Funding

Current Stage
Public Company
Total Funding
$455M
Key Investors
Blue Owl,HealthCare Royalty PartnersHercules Capital
2024-08-06Post Ipo Debt· $250M
2022-01-04Post Ipo Debt· $70M
2019-12-24Post Ipo Equity· $50M

Leadership Team

M
Mark Glick
VP Program Management
linkedin
Company data provided by crunchbase